Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

DSM and Cerapedics Partner to Develop Peptide Enhanced Bone Graft

 
DSM and Cerapedics will partner to develop and manufacture next-generation peptide enhanced bone graft. The strategic partnership aligns DSM’s regenerative materials capabilities with proprietary synthetic small peptide technology developed by Cerapedics.
 
DSM’s bioceramic platform is a carbonated apatite matrix used in bone graft substitute applications, which will be combined with Cerapedics’ growth factor in this partnership. The partnership will run from concept through commercialization.